Metabolic Engineering 101
February 5, 2015
Primers on the science of metabolic engineering.
1 min read
February 5, 2015
Primers on the science of metabolic engineering.
1 min read
February 5, 2015
In today’s aggressive, cost-cutting climate, the desire to switch from batch to continuous manufacturing is strong. As pharma companies embark on prolonged innovation cycles in an attempt to deliver the higher volumes and reduced costs of continuous manufacturing, it might surprise many that the technology they seek already exists.
1 min read
February 3, 2015
Having witnessed the evolution of operational excellence (OPEX), how do you implement it – and how do you ensure continued success? Here, we propose a new model.
1 min read
February 3, 2015
A new model for cocrystal formation could be a powerful tool for formulation scientists – no crystal structures required, it’s all about the surface contacts.
1 min read
February 3, 2015
If pharma is to retain its reputation as an innovator, companies must be brave enough to explore new areas, new targets and new technologies – and boldly go where no industry has gone before.
1 min read
February 3, 2015
Sitting Down With… Andy Skibo, Executive Vice President, Operations at MedImmune, and Chairman of the International Society for Pharmaceutical Engineering (ISPE).
1 min read
February 3, 2015
What’s convenient for manufacturers does not always result in a product that’s best for patients. In fact, sometimes it’s quite the opposite.
1 min read
February 3, 2015
Big pharma must be more agile if it wants to make the most of the revolutionary advances that will shape the next decade.
1 min read
February 3, 2015
Serialization will enable our industry to take up its rightful place in the ‘Internet of Things’.
1 min read
February 3, 2015
For the first time, stem cell therapy has been recommended for use in Europe
1 min read
February 3, 2015
Legal tussles continue over ‘drug takeback’ law in Californian county
1 min read
February 2, 2015
An ambitious UK sequencing project aims to learn more about patients with cancer and rare diseases
1 min read
February 2, 2015
EMA’s pilot project continues. Is the future of regulation adaptive?
1 min read
February 2, 2015
Are vaccines set for a makeover? Two innovative studies from researchers in Massachusetts demonstrate the creative new approaches that R&D scientists are taking to improve the efficacy – and convenience – of vaccination.
1 min read
February 2, 2015
Who are the top 100 most influential people in drug development and manufacturing today? That’s the question we’re aiming to answer with The Power List 2015. But we need your help…
1 min read
False
False